Spectranetics Adds Scoring Balloons With AngioScore Acquisition
This article was originally published in The Gray Sheet
Executive Summary
The $230 million deal for the maker of AngioSculpt balloon catheters will strengthen Colorado-based Spectranetics’ focus on vessel preparation and plaque modification, and expand its attention to coronary products.